These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8707502)

  • 1. The 'utility' of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off?
    Stiggelbout AM; Eijkemans MJ; Kiebert GM; Kievit J; Leer JW; De Haes HJ
    Int J Technol Assess Health Care; 1996; 12(2):291-8. PubMed ID: 8707502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What value health?: A review of health state values used in early technology assessments for NICE.
    Stein K; Fry A; Round A; Milne R; Brazier J
    Appl Health Econ Health Policy; 2005; 4(4):219-28. PubMed ID: 16466273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The "utility" of the Time Trade-Off method in cancer patients: feasibility and proportional Trade-Off.
    Stiggelbout AM; Kiebert GM; Kievit J; Leer JW; Habbema JD; De Haes JC
    J Clin Epidemiol; 1995 Oct; 48(10):1207-14. PubMed ID: 7561982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of computerized visual analog scale, time trade-off and standard gamble rating methods in patients and the public.
    Lenert LA; Sturley AE
    Proc AMIA Symp; 2001; ():364-8. PubMed ID: 11825211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility Measures in Pediatric Temporary Health States: Comparison of Prone Positioning Valuation Through 5 Assessment Tools.
    Shahjouei S; Vafaei Sadr A; Khorasani S; Nejat F; Habibi Z; Akbari Sari A
    Value Health Reg Issues; 2019 May; 18():97-105. PubMed ID: 30897544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sagittal craniosynostosis: a utility outcomes study.
    Kuta V; McNeely PD; Walling S; Bezuhly M
    J Neurosurg Pediatr; 2017 Aug; 20(2):113-118. PubMed ID: 28524791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an internet-based disease trajectory decision tool for prostate cancer screening.
    Bhatnagar V; Frosch DL; Tally SR; Hamori CJ; Lenert L; Kaplan RM
    Value Health; 2009; 12(1):101-8. PubMed ID: 18637139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility score of epilepsy with partial seizure measured by TTO, VAS, and EQ-5D in the general Korean population.
    Kang HJ; Kang E; Jo MW; Park EJ; Yoon S; Lee EK
    Epilepsy Res; 2014 Jul; 108(5):963-71. PubMed ID: 24679945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What utility scores do mental health service users, healthcare professionals and members of the general public attribute to different health states? A co-produced mixed methods online survey.
    Flood C; Barlow S; Simpson A; Burls A; Price A; Cartwright M; Brini S;
    PLoS One; 2018; 13(10):e0205223. PubMed ID: 30352071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health values of patients with systemic sclerosis.
    Khanna D; Ahmed M; Furst DE; Ginsburg SS; Park GS; Hornung R; Tsevat J
    Arthritis Rheum; 2007 Feb; 57(1):86-93. PubMed ID: 17266070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated current health time-trade-off assessments in women's health.
    Tosteson AN; Kneeland TS; Nease RF; Sumner W
    Value Health; 2002; 5(2):98-105. PubMed ID: 11918825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inconsistencies in TTO and VAS values for EQ-5D health states.
    Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
    Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach.
    Ramos-Goñi JM; Craig BM; Oppe M; Ramallo-Fariña Y; Pinto-Prades JL; Luo N; Rivero-Arias O
    Value Health; 2018 May; 21(5):596-604. PubMed ID: 29753358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-life valuations of advanced breast cancer by New Zealand women.
    Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
    Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.